- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03589937
Ocular Development and Refractive Error Changes Among Children and Adolescent - A Longitudinal Study
March 14, 2022 updated by: Yizhi Liu, Zhongshan Ophthalmic Center, Sun Yat-sen University
A Longitudinal Study on Ocular Development and Refractive Error Changes Among children-and Adolescent
The study aims to observe the ocular development and refractive error changes among school children and adolescents
Study Overview
Status
Active, not recruiting
Conditions
Detailed Description
This study aims to observe the refractive error changes of school children and adolescents for 3 years, and to collect data of ocular structural parameters, family history and environmental factors so as to understand the natural course and internal laws of myopia progression.
Study Type
Observational
Enrollment (Actual)
7050
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Guangdong
-
Guangzhou, Guangdong, China, 510000
- Zengcheng
-
Guangzhou, Guangdong, China
- Zengcheng
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
3 years to 12 years (Child)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
School children and adolescent at the age of 3(Junior Kindergarten), 6(Grade 1), 9(grade 4), 12(grade 7)
Description
Inclusion Criteria:
- School children and adolescent at the age of 3(Junior Kindergarten), 6(Grade 1), 9(grade 4), 12(grade 7).
- No allergy to tropicamide or topical anesthetics
- written informed consent is obtained from guardian
- Be willing to cooperate with the relevant ophthalmological examination and complete the questionnaire.
Exclusion Criteria:
- No history of eye diseases
- Receiving or has been received treatment of myopia control such as atropine eye drops, corneal contact lens or myopic glasses
- A history of allergy to topic amide or topical anesthetics
- Have severe systemic disease
- Missing ability to give informed consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
spherical equivalent change
Time Frame: examine every 12 months, follow up for 3 years
|
SE was measured by autorefractometer with cycloplegic once a year at scheduled time Every 12 months, follow up for 3 years
|
examine every 12 months, follow up for 3 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Axial length
Time Frame: examine every 12 months, follow up for 3 years
|
Axial length is measured by IOMaster once a year at scheduled time
|
examine every 12 months, follow up for 3 years
|
|
Anterior chamber depth
Time Frame: examine every 12 months, follow up for 3 years
|
Anterior chamber depth is measured by IOMaster once a year at scheduled time
|
examine every 12 months, follow up for 3 years
|
|
lens thickness
Time Frame: examine every 12 months, follow up for 3 years
|
lens thickness is measured by IOMaster once a year at scheduled time
|
examine every 12 months, follow up for 3 years
|
|
Vitreous length
Time Frame: examine every 12 months, follow up for 3 years
|
Vitreous length was measured by IOMaster once a year at scheduled time
|
examine every 12 months, follow up for 3 years
|
|
Environmental factor
Time Frame: examine every 12 months, follow up for 3 years
|
Time of outdoor activities & short range reading,measured by questionnaire
|
examine every 12 months, follow up for 3 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Yizhi LIU, PhD, Zhongshan Ophthalmic Center, Sun Yat-san University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 20, 2018
Primary Completion (Anticipated)
July 20, 2024
Study Completion (Anticipated)
July 20, 2024
Study Registration Dates
First Submitted
June 20, 2018
First Submitted That Met QC Criteria
July 17, 2018
First Posted (Actual)
July 18, 2018
Study Record Updates
Last Update Posted (Actual)
March 29, 2022
Last Update Submitted That Met QC Criteria
March 14, 2022
Last Verified
March 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SYSU-OPH-004
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Myopia
-
Tianjin Medical University Eye HospitalNot yet recruitingProgressive Myopia | Pediatric Myopia | Orthokeratology-related Myopia Progression
-
Shanghai General Hospital, Shanghai Jiao Tong University...Not yet recruitingMyopia | Myopia, ProgressiveChina
-
SightGlass Vision, Inc.Recruiting
-
University of FaisalabadCompletedRefractive Errors | Myopia | Progressive MyopiaPakistan
-
SightGlass Vision, Inc.RecruitingMyopia | Myopia Progression | Juvenile MyopiaUnited States
-
Shanghai Eye Disease Prevention and Treatment CenterEnrolling by invitationMyopia, Child Myopia ProgressionChina
-
He Eye HospitalNot yet recruiting
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityActive, not recruiting
-
University Eye Hospital, FreiburgActive, not recruiting
-
University of BradfordUniversity of Huddersfield; CooperVision International Limited (CVIL)Enrolling by invitationMyopia, ProgressiveUnited Kingdom